Neuromodulation for constipation and fecal incontinence

Area of Science:

• Gastroenterology and Urology
• Minimally Invasive Surgery
• Neuromodulation

Background:

• Severe fecal incontinence and idiopathic constipation present significant challenges for patients unresponsive to conservative management.
• Current surgical options for these conditions are invasive and carry risks, often with uncertain outcomes.
• Sacral neuromodulation (SNM) offers a less invasive alternative with a pre-implantation testing phase.

Purpose of the Study:

• To evaluate the efficacy of permanent SNM in patients with severe fecal incontinence resistant to medical treatment.
• To explore the potential of SNM as a treatment option for patients with chronic constipation who have failed maximal medical therapy.

Main Methods:

• Review of evidence and case series on the use of SNM for fecal incontinence and constipation.
• Assessment of SNM as a minimally invasive treatment preceding major surgical intervention.
• Analysis of patient outcomes in early studies of SNM for constipation.

Main Results:

• Permanent SNM demonstrates substantial improvement in continence for patients with severe fecal incontinence.
• Early case series indicate encouraging results for SNM in the treatment of constipation.
• SNM provides a viable alternative to bowel resection or stoma formation for refractory constipation.

Conclusions:

• SNM is a valuable, minimally invasive treatment for severe fecal incontinence, offering a testing phase before definitive implantation.
• SNM shows significant potential for treating patients with idiopathic constipation who have failed conservative and maximal medical treatments.
• Further larger trials are needed to confirm the benefits of SNM for constipation, but it represents an important future treatment option.